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 Introductions: Ovarian cancer is seventh leading cause of cancer death 
among women. Ovarian mass has age specific occurrence and may 
may help in screening and management plans. This study was 
conducted to determine the age-wise clinical profile of the ovarian mass. 
 
Methods: This review done to analyse the histologically diagnosed 
ovarian masses in cases operated during three years at Patan Hospital, 
Patan Academy of Health Sciences, Nepal. Clinical profile of the patients 
and age-wise distribution of histological types of ovarian mass were 
analyzed descriptively using Microsoft Excel. 
 
Results: Peak incidence of ovarian tumor was in age group of 20-29 years 
with 93 (36%) cases out of 258 ovarian masses. All eight malignant 
tumors were in age group of ≥40 years. Neoplastic masses were 188 
(72.9%), 95 (50.5%) germ cell tumor. In 70 (27.1%) non-neoplastic lesion, 
corpus luteal cyst were 24 (34.3%).  
 
Conclusions: Peak incidence of ovarian tumor was seen in age group of 
20-29 years. Germ cell tumors accounted for half of the neoplastic 
lesions. All malignant ovarian tumors were in found in age group ≥40 
years. 
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Ovarian mass can occur in all age groups.1 
About 80% of all are benign and mostly seen 
in age group of 20-45 years.2 Ovarian cancer 
accounts for 2.5% of all malignancies and is 
the 7th leading cause of cancer death among 
women worlwide.3 There are 2 to 6 new cases 
per 100000 women per year in Asia.4 Study 
from Nepal shows benign ovarian mass 
accounts for 80-90% with peak incidence in 
age group of 20-40 years.5-7 
 
Many non-neoplastic lesions of the ovary 
mimic ovarian neoplasms clinically and 
radiologically, and therefore, a histological 
classification is important to decide 
appropriate therapy.8,9 There is a clear age 
distribution for these masses, which can serve 
as a useful guide for appropriate screening 
and management strategies.  
 
This study aims to analyse the age-wise 
distribution of the various types of ovarian 
masses in local setup to serve as a baseline 






This was a cross-sectional study done at 
Department of Obstetrics and Gynecology, 
Patan Hospital, Patan Academy of Health 
Sciences (PAHS), Nepal, during three years 
period from January 2015 to December 2017. 
Data were collected from the hospital 
database with discharge diagnosis of ovarian 
mass. The individual files for each patient 
were obtained from the hospital record 
section and only those with histopathology 
report were included for analysis. World 
Health Organization (WHO) classification of 
ovarian tumors 2002 was used for classifying 
the tumors.10 Ethical approval was obtained 
from the institutional review committee (IRC) 






Out of total 258 ovarian masses, 93 (36%) 
were in age group 20-29 years, followed by 61 
(23.6%) in 30-39 years. All eight (3.1%) 
malignant tumors were seen in age group ≥40 
years and among them, five in age group of 
50-59 years. Mature cystic teratoma were 93 
(36% of 258 ovarian mass), all benign, Table 1. 
 
Out 258 ovarian masses, non-neoplastic were 
70 (27.1%), Corpus luteal cyst 24 (34.3 %), 
Table 2. 
 
Among 188 (72.9) neoplastic lesions, 177 
(94.1%) were benign, 8 (4.3%) malignant and 

























≤ 19 8 12 5 0 0 25 (9.7 %) 
20-29 28 43 21 1 0 93 (36 %) 
30-39 14 20 27 0 0 61 (23.6 %) 
40-49 20 11 18 0 0 49 (19 %) 
50-59 0 6 12 1 1 20 (7.7 %) 
60-69 0 3 5 0 1 9 (3.5 %) 
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Table 2. Distribution of various non-neoplastic tumors (N=70) 
 
 
Types of non-neoplastic lesions N (%) 
Corpus luteal cyst 24 (34.3 %) 
Simple cyst 18 (25.7%) 
Endometrioid cyst 13 (18.6 %) 
Hemorrhagic cyst  12 (17.1%) 
Follicular cyst 3 (4.3 %) 
Table 3. Distribution of various neoplastic ovarian tumors (N=188) 
 
 
Neoplastic ovarian tumors Nature Types of lesion N (%)  
Germ cell tumor, 95 (50.5%) Benign Mature cystic teratoma 93 (49.5%) Struma ovarii 2 (1%)  
Surface epithelial tumor, 
89 (47.3%) 
Benign Serous 52 (27.7%)  Mucinous 26 (13.8%) 
Borderline Serous 1 (0.5%) Mucinous 2 (1%) 
Malignant Serous 5 (2.7%) Mucinous 3 (1.6%) 
Sex-cord stromal tumor, 2 (1%) Benign Fibroma 2 (1%) 




This study showed most common age group 
for occurrence of ovarian tumor was in 20-29 
years (36%), followed 30-39 years (23.6%), 
similar with the findings of other 
studies.6,11,12,18,19  Ovarian tumor may occur at 
any age, including infancy and childhood.18 
The peak incidence is between 21 to 40 years 
and about 80% are benign.2,12 This study 
showed that in age group of ≤19 years 48% 
were germ cell tumors, less common than the 
95% reported in a study ‘germ cell teratoma 
in children’.20 
 
All eight malignant tumors in this study were 
found in ≥40 years. Malignant tumors are 
reported more commonly in older women, 
between the ages of 45 and 65 years.2 
Ovarian tumors are challenging as both non-
neoplastic and neoplastic lesions present with 
similar clinical and radiological features. It is 
one of the reasons for prophylactic 
oophorectomies and hysterectomies. Early 
diagnosis is difficult due to its asymptomatic 
nature, inaccessible site and the limited use of 
various new techniques like cytology and 
biopsy.9 More than 70% of women with 
ovarian cancer are diagnosed in advanced 
stage with high fatality rate. Five-year survival 
rates for women with advanced disease range 
from 20% to 30% and early stages the cure 
rates are as high as 70% to 90%, and better 
survival related with age at presentation.21  
 
This study showed a peak incidence of benign 
ovarian tumor between 2nd and 4th decade of 
life and malignant tumor after 4th decade. 
Thus, screening test like CA-125, abdominal 
and transvaginal sonography seems more 
appropriate in this age group of above 40 
years for early detection of malignant ovarian 
mass.  
 
In this study, 72.9% cases were neoplastic, 
and among them only 4.3% were malignant, 
less than 15.7%7 reported earlier from our 
hospital on 363 ovarian tumors during three 
years data 2011-2013. One possible 
explanation could be, in earlier study the 
pathology department used to process 
samples from other hospitals in and around 
Kathmandu valley. However, this study did 
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demography of the samples which may 
represent geographical variation of 
malignancy or only suspicious malignant 
samples from outside were sent to our center 
for final histological confirmation. 
 
In present study majority of non-neoplastic 
tumors were corpus luteal cyst (34.3%) 
followed by simple cyst of ovary (25.7%). Non-
neoplastic lesions are commonly occurring 
ovarian lesions.12 Similar findings of corpus 
luteal cyst have been reported.13,15  
 
Ovarian tumor has heterogenicity in 
histological pattern although looks similar in 
gross examination and WHO classification is 
also based on histogenesis of normal ovary. 
Surface epithelial tumors are the commonest 
according to this classification comprising 
48.8% and 63.5% of all ovarian tumors in 
different studies while their malignant 
counterparts comprise approximately 90% of 
all ovarian cancers.12 
 
But in present study, majority of tumors 
according to the WHO classification were of 
germ cell origin (51.6 %) followed by surface 
epithelial tumor which correspond to the 
earlier findings from our hospital7 but 
contradict to other studies5,6,12 in which 
majority of tumors were of surface epithelial 
origin, Table 4.  
 
Table 4. Comparative incidence of neoplastic ovarian tumors 
 
 
Types of ovarian tumor R Jha et al.5 SK Maondal et al.12 S Vaidya et al.7 Current Study 
Surface Epithelial Tumor 52.2% 67.9% 43.5% 47.3% 
Germ-cell Tumor 42.2% 23.1% 51.5% 51.6% 
Sex-cord Stromal Tumor 3.1% 5.6% 3.3% 1.1% 
 
The variation in types of tumor in different 
studies from Nepal may be due to the 
differences in risk factors or exposures and 
demographic characteristics and demands 
further studies. 
 
In present study our main focus was age 
group and ovarian mass, and analysis of 
further risk factors in multicentric pooled data 





Our findings show benign ovarian tumors 
were more common than malignant, and 
germ cell tumors were common histologic 
type in all age groups. Peak incidence of 
ovarian tumor was in age group of 20-29 
years. Mature cystic teratoma was the most 
common benign tumor. Serous carcinoma was 
the commonest malignancy occurring after 4th 
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